Concord New Energy

Concord New Energy Group Limited

Company type	Public
Industry	Renewable energy, wind power, solar power, engineering
Predecessor	Nam Pei Hong (Holding) Limited, Nam Pei Hong International Holdings Limited, N P H International Holdings Limited, Hong Kong Pharmaceutical Holdings Limited, China Windpower Group Limited
Founded	1984
Headquarters	Admiralty, Hong Kong , Hong Kong
Area served	China, Hong Kong
Key people	Johnson Ko Chun-shun (former chairman and vice-chairman)
Products	Engineering, procurement and construction of wind power facilities; operation and maintenance of wind farms; manufacturing of wind power equipment; solar power plants

Concord New Energy Group Limited is a publicly traded investment holding company listed on the Hong Kong stock exchange. Its main office is located in Admiralty, Hong Kong, with an additional management office based in Beijing. The company, along with its subsidiaries, specializes in the engineering, procurement, and construction (EPC) of wind power facilities, as well as the operation and maintenance of wind farms, manufacturing of wind power equipment, and associated business activities. Over time, the listed entity and its predecessors have operated under various names including Nam Pei Hong (Holding) Limited, Nam Pei Hong International Holdings Limited, N P H International Holdings Limited, Hong Kong Pharmaceutical Holdings Limited, and most recently China Windpower Group Limited.

History

Between 2000 and 2007, the company was identified as Hong Kong Pharmaceutical Holdings Limited (香港葯業/香港藥業/港葯/港藥). Before that period, it was known as "N P H International Holdings Limited" from 1997 to 2000, and briefly as Nam Pei Hong International Holdings Limited in 1997. From 2007 until 2015, the firm operated under the name China WindPower Group Limited.

Nam Pei Hong International

Nam Pei Hong International Holdings was established as an offshore corporation incorporated in Bermuda. The term Nam Pak Hong (南北行) traditionally referred to trading enterprises involved in importing and exporting goods from China. Although Bonham Strand earned the nickname "Nam Pak Hong street," the listed company neither had its headquarters there nor owned real estate on that street. This entity was the parent company of Nam Pei Hong Sum Yung Drugs Company Limited (南北行參茸葯材有限公司), which specialized in traditional Chinese medicinal products such as dried abalone, birds' nests, dried scallops, and ginseng.

Prior to 1997, the business operated locally in Hong Kong as Nam Pei Hong (Holding) Limited (南北行（集團）有限公司), a company incorporated in 1984 and publicly listed since 1991. After establishing the Bermuda holding company in 1997, Nam Pei Hong (Holding) became its subsidiary and was renamed Foster (Group) Limited between 1998 and 2000. As of March 2006, it remained wholly owned by the group.

Following the company’s transformation into an investment vehicle through a backdoor listing process, the Nam Pei Hong segment was sold in 2009 to shareholder Johnson Ko for HK$34 million. Subsequently, Nam Pei Hong (Holding) was officially dissolved by striking off in 2010. Nevertheless, by 2019, former subsidiaries such as Nam Pei Hong Sum Yung Drugs and N P H Sino-Meditech Limited were still operational.

Hong Kong Pharmaceutical

In 1996, Heilongjiang Economic Development Corp. acquired a controlling interest in the listed company. The Hong Kong Stock Exchange criticized both the firm and its former executives for delayed disclosure regarding this acquisition. In July 1997, Victory Hunter Holdings—owned by Yau Wai-ming of Heilongjiang provincial government—purchased a 33% stake from International Tak Cheung Holdings. By 1999, Yau transferred Victory Hunter’s shares to Hong Tau Investment for HK$1. Two directors, Sun Hiu-lu and Chu Kwan, held a combined 51% interest in Hong Tau through Welcome Success Worldwide Limited; however, they did not control Welcome Success itself. The remaining 49% was owned by Heilongjiang Economic Development (later Heilongjiang China United Co., Ltd.) alongside Heilongjiang International Trust Investment Corporation. As of September 2003, Hong Tau maintained a majority holding of 67.2%. Reports indicate Sun acquired this stake from Yau in 1999, which led to fluctuations in the share price.

The company was renamed Hong Kong Pharmaceutical Holdings Limited in 2000 and expanded its operations by acquiring multiple Mainland China enterprises. However, mismanagement under new ownership brought it close to liquidation by 2004.

In 2005, Johnson Ko Chun-shun purchased an 85.2% controlling interest from the liquidator and proceeded to sell two Mainland subsidiaries to bondholders. The firm intended to realign its focus on the Nam Pak Hong trading business, which Ko subsequently sold in 2009. Johnson Ko served as chairman between 2006 and 2009 before transitioning to vice-chairman. Following a reverse takeover in 2007, he remained a significant shareholder until May 2015 when he divested most of his holdings through Gain Alpha, reducing his ownership from 22.36% to 2.24%. Both Johnson Ko and his daughter Samantha Ko Wing-yan resigned from their directorships in June 2015.

After being suspended for over two years, trading resumed in December 2006 with shares closing at HK$0.47—a drop of HK$1.47 compared to previous levels.

China WindPower Group

In April 2007, Hong Kong Pharmaceutical completed a reverse IPO to acquire China Wind Power Holdings Limited, subsequently renaming the publicly listed entity as China WindPower Group Limited. The company and its affiliates specialized in the engineering, procurement, and construction (EPC) sector, along with operation and maintenance of wind power facilities, manufacturing of wind energy equipment, and associated activities.

By 2009, CLP Group had purchased a 50% interest in a subsidiary of China WindPower for HK$101.3 million. This partnership formed the joint venture CLP-CWP Wind Power Investment Limited, which managed wind farms located in Fuxin, Liaoning Province, China.

Concord New Energy

The organization underwent rebranding in 2015 to become Concord New Energy Group Limited, signaling a strategic pivot towards solar energy following its acquisition of solar power plants in 2011. From 2014 onward, the majority of its newly installed capacity was derived from solar sources.

Although bond issuance was paused in November 2017, Concord New Energy resumed public offerings by January 2018. In 2017, Fitch Ratings assigned the company a credit rating of "BB−."

In 2018, Concord New Energy became part of a consortium that provided venture capital to Malta Inc., an Alphabet Inc. spin-off.